432 related articles for article (PubMed ID: 25480109)
21. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
22. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
Salie R; Alsalhin AKH; Marais E; Lochner A
Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
[TBL] [Abstract][Full Text] [Related]
23. Puncta of Neuronal Nitric Oxide Synthase (nNOS) Mediate NMDA Receptor Signaling in the Auditory Midbrain.
Olthof BMJ; Gartside SE; Rees A
J Neurosci; 2019 Jan; 39(5):876-887. PubMed ID: 30530507
[TBL] [Abstract][Full Text] [Related]
24. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
25. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium.
Brixius K; Bloch W; Ziskoven C; Bölck B; Napp A; Pott C; Steinritz D; Jiminez M; Addicks K; Giacobino JP; Schwinger RH
Can J Physiol Pharmacol; 2006 Oct; 84(10):1051-60. PubMed ID: 17328145
[TBL] [Abstract][Full Text] [Related]
26. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
Maffei A; Di Pardo A; Carangi R; Carullo P; Poulet R; Gentile MT; Vecchione C; Lembo G
Hypertension; 2007 Oct; 50(4):652-6. PubMed ID: 17664392
[TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP⁺ cytotoxicity.
Kurauchi Y; Hisatsune A; Isohama Y; Sawa T; Akaike T; Katsuki H
Neuroscience; 2013 Feb; 231():206-15. PubMed ID: 23238575
[TBL] [Abstract][Full Text] [Related]
29. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
Bellingham M; Evans TJ
Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
Baliga RS; Preedy MEJ; Dukinfield MS; Chu SM; Aubdool AA; Bubb KJ; Moyes AJ; Tones MA; Hobbs AJ
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7428-E7437. PubMed ID: 30012589
[TBL] [Abstract][Full Text] [Related]
31. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
32. Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.
Hermida N; Michel L; Esfahani H; Dubois-Deruy E; Hammond J; Bouzin C; Markl A; Colin H; Steenbergen AV; De Meester C; Beauloye C; Horman S; Yin X; Mayr M; Balligand JL
Eur Heart J; 2018 Mar; 39(10):888-898. PubMed ID: 29106524
[TBL] [Abstract][Full Text] [Related]
33. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
[TBL] [Abstract][Full Text] [Related]
34. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
[TBL] [Abstract][Full Text] [Related]
35. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.
Aragón JP; Condit ME; Bhushan S; Predmore BL; Patel SS; Grinsfelder DB; Gundewar S; Jha S; Calvert JW; Barouch LA; Lavu M; Wright HM; Lefer DJ
J Am Coll Cardiol; 2011 Dec; 58(25):2683-91. PubMed ID: 22152956
[TBL] [Abstract][Full Text] [Related]
36. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.
Vaniotis G; Glazkova I; Merlen C; Smith C; Villeneuve LR; Chatenet D; Therien M; Fournier A; Tadevosyan A; Trieu P; Nattel S; Hébert TE; Allen BG
J Mol Cell Cardiol; 2013 Sep; 62():58-68. PubMed ID: 23684854
[TBL] [Abstract][Full Text] [Related]
38. What is next in nitric oxide research? From cardiovascular system to cancer biology.
Bian K; Murad F
Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
[TBL] [Abstract][Full Text] [Related]
39. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
40. Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway.
Chen L; Zhou X; Deng Y; Yang Y; Chen X; Chen Q; Liu Y; Fu X; Kwan HY; You Y; Jin W; Zhao X
J Ethnopharmacol; 2023 Jan; 300():115705. PubMed ID: 36099983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
